The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies
EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults
AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey
The integration of Ashfield Health marketing and communications specialty agencies into the Evoke platform has been under way since October 2021
MedicalKnowedgeGroup (MKG) companies address the business needs of biopharmaceutical companies through the provision of network-mapping analytics, patient-finding analytics, and multi-channel marketing solutions
This year, UBC has partnered with Seqster and acquired Marketshare Movers to advance the company’s capabilities in clinical trials and co-pay and affordability programs
Phil, Inc. is a software therapy deployment platform, offering pharmaceutical manufacturers a modern alternative to traditional access, affordability and distribution options
CoAssist Pharmacy streamlines the prescription process for healthcare providers and home delivery of JATENZO for patients